Lumeran, Jerald Kurt D.

HRN: 21-74-74  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2022
CEFTRIAXONE 1G (VIAL)
08/04/2022
08/10/2022
IV DRIP
1.5g
OD
Wbc 19. Anemia ETBD, T/C Liver Pathology
Waiting Final Action 
08/06/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/06/2022
08/12/2022
IVT
225
Q24
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: